Implementation Guide CH VACD
4.0.1 - trial-use
This page is part of the CH VACD (R4) (v4.0.1: STU 4) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Generated Narrative: Medication
Resource Medication "TC-IMMUN-MEDIC-HAVRIX1440"
Profile: CH VACD Medication For Immunization
identifier: id: 359000dc-2cee-4a6e-ab05-577f558840e2
code: HAVRIX 1440 Inj Susp (unknown#7680005580054)
status: active
manufacturer: Organization/TC-ORG-GSK "GlaxoSmithKline AG"
form: Suspension for injection (EDQM - Standard Terms#11202000)
amount: 1 milliliter (Details: UCUM code mL = 'mL')/1 Syringe (unit of presentation) (Details: SNOMED CT code 733020007 = 'Syringe')
Item[x] |
Immunologic substance (substance) (SNOMED CT#106181007) |
LotNumber |
AHAVB946A |